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The mitogen-activated protein kinase (MAPK) p38α is a key regulator in many cellular processes, whose activity is tightly 
regulated by upstream kinases, phosphatases and other regulators. Transforming growth factor-β activated kinase 1 (TAK1) is 
an upstream kinase in p38α signaling, and its full activation requires a specific activator, the TAK1-binding protein (TAB1). 
TAB1 was also shown to be an inducer of p38α’s autophosphorylation and/or a substrate driving the feedback control of p38α 
signaling. Here we determined the complex structure of the unphosphorylated p38α and a docking peptide of TAB1, which 
shows that the TAB1 peptide binds to the classical MAPK docking groove and induces long-range conformational changes on 
p38α. Our structural and biochemical analyses suggest that TAB1 is a reasonable substrate of p38α, yet the interaction between 
the docking peptide and p38α may not be sufficient to trigger trans-autophosphorylation of p38α. 
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The mitogen-activated protein kinase (MAP kinase, MAPK) 
signaling plays important roles in various cellular processes 
[1]. A conventional MAPK pathway is composed of three 
tiers of sequentially activated kinases, termed MAPK kinase 
kinase (MKKK), MAPK kinase (MKK) and MAPK. In the 
canonical MAPK pathway, the upstream MAPK kinase ki-
nase phosphorylates and activates the MAPK kinase, which 
in turn phosphorylates and activates the downstream MAPK. 
The p38 kinases are a subgroup of MAPK family, compris-
ing of four isoforms, α, β, γ and δ. These serine/threonine 
kinases are highly conserved and involved in inflammatory 
responses, differentiation, tumor suppression, cell cycle and 
apoptosis [2,3]. Two members of MKK family, MKK3 and 
MKK6, have high activity toward p38 MAPKs. MKK3 ap-
pears to favor the p38α and p38β isoforms, while MKK6 
phosphorylates all p38 family members. Both MKK3 and 
MKK6 are dual-specificity kinases capable of phosphory-
lating two adjacent Thr and Tyr residues (the Thr-Gly-Tyr 
motif) in the activation loop of p38 MAP kinases [4]. Upon 
dual phosphorylation, the p38 MAPKs become active and 
consequently phosphorylate a large set of substrates such as 
transcription factors, tumor suppressors and other kinases.  
Although the canonical cascade is considered to be the 
principal activation mechanism of MAPK, three alternative 
mechanisms have been reported for p38α. One involves the 
direct interaction of p38α with TGF-β-activated protein ki-
nase 1 binding protein 1 (TAB1), which results in the auto-
phosphorylation and activation of p38α [5]. The second 
MKK-independent pathway, exclusively in T-cells, involves 
phosphorylation of Tyr323 on p38α by the ZAP-70 tyrosine 
kinase, which leads to p38α autophosphorylation solely on 
Thr180 of the Thr-Gly-Tyr motif and thus activates p38α 
[6,7]. In addition, evidence indicates that phosphatidylino-
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sitol ether lipid analogues can activate p38α via MKK in-
dependent and dependent mechanisms [8,9]. 
The TGF-β-activated protein kinase 1 (TAK1) is a MKKK 
in p38 signaling pathway and plays an important role in the 
regulation of p38 activity by phosphorylating and activating 
MKK3 and MKK6 [10]. TAB1 was originally identified as 
a key regulator of TAK1 that binds directly to the kinase 
domain of TAK1 and promotes autophosphorylation of two 
threonine residues (Thr184 and Thr187) and one serine res-
idue (Ser192) within the activation loop of TAK1 kinase 
[11–13]. Ge et al. [5] later found that TAB1 can interact 
with p38α but no other p38 family members, and the inter-
action of TAB1 with p38α leads to dual autophosphoryla-
tion of p38α on both Thr and Tyr sites, in vitro and in vivo. 
The TAB1-dependent p38α activation appears to play im-
portant roles in some physiological and pathological pro-
cesses, such as injury during myocardial ischemia, matura-
tion of monocyte-  derived dendritic cells, maintenance of 
peripheral T-cell anergy, and intracellular infection of para-
site induced interleukin-12 production [1,14–17]. On the 
other hand, Cheung et al. [18] suggested that the activated 
p38α can phosphorylate TAB1, which feedback controlled 
the activation of TAK1 and reduced the sequential activa-
tion of MKK3/6 and p38α. To understand the molecular 
basis for TAB1- enhanced p38α autophosphorylation, we 
solved the crystal structure of p38α-TAB1 peptide complex 
at 2.7 Å resolution, with the classical hydrophobic docking 
groove on p38α accommodating the TAB1 peptide via both 
hydrophobic and hydrophilic interactions. The TAB1-  
induced conformational changes of p38α and further bio-
chemical analyses elucidate the role of the p38α-TAB1 in-
teraction.  
1  Materials and methods 
1.1  Cloning, expression, and purification 
The cDNAs encoding mouse p38α and human MKK6CA 
(207E/T211E) were generous gifts from Dr. Wu ZhenGuo, 
the cDNA of human TAB1 was kindly provided by Dr. Han 
JiaHuai, and the plasmid of pGEX-4T-1-ATF2 (1–109) was 
a generous gift from Dr. Choi Eui-Ju. The p38α and 
MKK6CA were subcloned into pETDuet-1 (Novagen), and 
overexpressed in BL21 (DE3) cells. The N-terminal 
His6-tagged bisphosphorylated p38α (p38α/pTpY) was pu-
rified through Ni-NTA column (Qiagen) and ion exchange 
column (Source 15Q, GE Healthcare). The site-specific 
mutations of TAB1 were generated by standard quick 
change PCR procedure and verified by sequencing. All 
TAB1 constructs were subcloned into pET21b (Novagen), 
and purified as aforementioned. The GST-tagged ATF2 
(1-109) was purified via GST affinity column (GE 
Healthcare) and Source 15Q anion exchange chromatog-
raphy. The construct of p38α-pepTAB1 fusion protein was 
generated by overlap PCR procedure, and subcloned into 
vector pET21b. The fusion protein for crystallization was 
purified through Ni-NTA and Source 15Q columns and 
further polished by size exclusion chromatography (Super-
dex 200, GE Healthcare). The final concentration was up to 
15 mg mL1 and stored in buffer containing 10 mmol L1 
Hepes pH 7.4, 150 mmol L1 NaCl and 2 mmol L1 DTT. 
Protein stocks for kinetic analyses were supplemented with 
glycerol at a final concentration of 20% (v/v).  
1.2  Kinetic analyses of p38α 
The autophosphorylation of p38α was carried out at 25C in 
reaction buffer containing 50 mmol L1 Hepes pH 7.4, 20 
mmol L1 MgCl2, while the TAB1-induced p38α autophos-
phorylation was performed in the same buffer supplemented 
with equal molar of wild type TAB1. At indicated time in-
tervals, aliquots were removed from the reservoir. After 4 h, 
some 200 nmol L1 of MKK6CA was introduced into the 
reaction system, and samples were taken at 10 and 30 min 
intervals. All samples were then analyzed by Western blot-
ting using phosphor-Thr (catalog number 9381S, Cell Sig-
naling Technology, Inc.) and phosphor-Tyr antibodies (cat-
alog number 9411, Cell Signaling Technology, Inc.). TAB1 
or ATF2 (5 μmol L1) was phosphorylated by dual phos-
phorylated p38α/pTpY. At indicated time intervals, aliquots 
were removed from the reservoir and then analyzed by 
Western blotting using phosphor-Thr antibody.  
1.3  Crystallization and structure determination  
Crystals of p38α-pepTAB1 fusion protein were grown using 
the hanging-drop vapor diffusion method at room tempera-
ture by mixing the protein with an equal volume of reservoir 
solution containing 100 mmol L1 Hepes, pH 7.86 and 22% 
polyacrylic acid 5100. Fresh crystals were quickly trans-
ferred to the cryo-protectant buffer containing reservoir 
solution supplemented with 25% (v/v) Ethylene Glycol and 
then flash-frozen under a cold nitrogen stream at 100 K. 
The diffraction data was collected at Shanghai Synchrotron 
Radiation Facility beamline 17U with a Mar225 CCD de-
tector, and processed by HKL2000 [19]. The structure was 
solved by molecular replacement using Phaser [20] with the 
p38-pepMKK3b complex (PDB ID: 1LEZ) as search 
model, and then refined with PHENIX [21] and Coot [22]. 
PROCHECK [23] was used to analyze the model stereo-
chemistry. All structural representations were prepared with 
PyMOL (http://www.pymol.org). 
2  Results and discussion 
2.1  Biochemical properties of TAB1  
We purified the full-length TAB1 and p38α proteins and 
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examined their interaction by gel filtration assay. When 
eight micromolar equivalents of p38α were mixed with 
three micromolar equivalents of full-length TAB1, a small 
amount of p38α was shifted to earlier fractions and 
co-migrates with TAB1, while the excess amount of p38α 
was eluted as a monomer (Figure 1A). This result clearly 
indicates that TAB1 and p38α can form a binary complex in 
solution. To test the biochemical consequences of the 
TAB1-p38α complex, we first performed in vitro kinase 
assays using the dual phosphorylation of Thr180 and 
Tyr182 in the activation loop of p38α as the readout of p38α 
autophosphorylation. As shown in Figure 1B, p38α was 
incapable of undergoing autophosphorylation, whereas the 
presence of TAB1 triggered the autophosphorylation of 
p38α. However, the TAB1-induced phosphorylation re-
quires hours to achieve significant stoichiometry (2%5%), 
suggesting that the p38α autophosphorylation is unlikely to  
contribute significantly to the in vitro activation of p38α. 
On the other hand, this p38α preparation used in our ex-
periments could be rapidly phosphorylated by its upstream 
kinase MKK6CA (Figure 1B). We also assessed kinase ac-
tivity of the dual phosphorylated p38α/pTpY toward ATF2 
and TAB1 (Figure 1C). As reported, ATF2 was efficiently 
phosphorylated by the activated p38α/pTpY and approached 
a plateau in approximately 2 h. In comparison, although 
TAB1 can be phosphorylated by p38α, the phosphorylation 
rate of TAB1 was approximately 10-fold slower than that of 
p38α-catalyzed ATF2 phosphorylation. These data demon-
strate that TAB1 used in our experiments can interact with 
p38α directly and is a good substrate for p38α MAP kinase. 
Since TAB1 is an essential activator of the p38α upstream 
kinase TAK1 [10] and the phosphorylation sites on TAB1 
lie in the proximity of its TAK1-interacting motif [18], it 
comes naturally that the TAB1 phosphorylation by p38α  
 
 
Figure 1  Biochemical studies of p38α and TAB1. A, In vitro interaction analysis between p38α and TAB1. The profiles of size exclusion chromatography 
are shown for p38α alone (blue), TAB1 alone (green) and their mixture (red). The corresponding SDS-PAGE results are shown on the right and boxed in 
respective color. B, TAB1-induced autophosphorylaiton of p38α on both Thr180 and Tyr182 in the activation loop. At indicated time intervals, aliquots of the 
reaction were removed and subjected to Western blot analysis using either anti-pThr or anti-pTyr antibodies. C, p38α/pTpY-catalyzed TAB1 
phosphorylation. The phosphorylation rate of p38α/pTpY towards its classical substrate ATF2 is shown for comparison. The reaction mixture contains 1 
nmol L1 of p38α/pTpY and 5 μmol L1 of TAB1 or ATF2. 
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might induce a conformational change of TAB1, impair the 
TAB1-TAK1 interaction and ultimately downregulate the 
TAB1-mediated TAK1 activation. Such a feedback inhibi-
tion is key to the intricate regulation of the TAK1-p38α 
signaling [2426]. 
2.2  Overall structure of p38α-pepTAB1 complex  
Many MAPK interacting proteins have a conserved kinase 
interaction motif (KIM) or docking motif (D motif) with the 
consensus sequence of (R/K)1 to 2-(X)2-6-ΦA-X-ΦB, where ΦA 
and ΦB represent the hydrophobic residues [15]. Zhou et al. 
[27] previously showed that TAB1 also contains a KIM 
sequence (residues 395414) that plays a major role in 
high-affinity p38α binding. We thus carried out crystalliza-
tion trials of p38α in complex with TAB1, but all efforts 
failed. We then generated fusion proteins in which a 
21-residue peptide of TAB1 (residues 395415, pepTAB1) 
was fused to the C-terminus of p38α. This p38α-pepTAB1 
complex structure was determined to 2.7 Å resolution, and 
the statistics for data collection and structure refinement are 
summarized in Table 1.  
In the complex, p38α adopts the classical bilobal kinase 
fold, consisting of a small β-stranded N-lobe and a    
larger α-helical C-lobe (Figure 2A). The TAB1 peptide  
Table 1  Data collection and refinement statistics 
Data collectiona) p38α-pepTAB1 
Space group P3121 
Cell dimensions 
a, b, c (Å) 
α, β, γ (°) 
 
82.1, 82.1, 122.6 
90, 90, 120 
Wavelength (Å) 0.979413 
Resolution (Å) 50.02.7 (2.762.71)b) 
Completeness (%) 96.1 (100.0)a) 
Average I/σI 21.1 (4.9) 
Redundancy 5.5 (6.0) 
Rmerge 
Total number of observations 





Resolution (Å) 2.7 
Number of reflections 13001 
Rwork/Rfree (%) 













Rmsd in bond length (Å) 0.010 
Rmsd in bond angles (°) 1.241 
Ramachandran-plot statistics  
Favored regions (%) 91.6 
Allowed regions (%) 8.4 
Disallowed regions (%) 0 
a) Each data set was collected from a single crystal. b) Values in pa-
rentheses are for the highest resolution shell. 
(406TLSLVMPS413) was clearly visible and binds from the 
back of the active site, to a groove on the kinase C-lobe 
(Figure 2B and C). The final model contains residues 4354 
of p38α and residues 406413 from the TAB1 peptide, and 
the extreme C-terminal 6 amino acids of p38α and the adja-
cent N-terminal 11 amino acids of TAB1 peptide were un-
traceable. In our crystallization experiments, the TAB1 pep-
tide was fused to p38α. One potential caveat of the fusion 
approach is that the structure may deviate from that of the 
natural complex due to constraint in the movement of two 
fused proteins/peptides. It is important to note that the Cα 
distance between the C-terminal Asp354 of p38α and the 
N-terminal Thr406 of the TAB1 peptide is approximately 
22 Å (Figure 2B), which would be readily covered by only 
seven residues. Thus, the 17 disordered residues of the 
p38α-pepTAB1 fusion protein probably form a flexible and 
long enough linker. We believe that the conformation of 
p38α-pepTAB1 complex is unlikely an “artifact” of the fu-
sion protein.   
2.3  The KIM docking site on p38α  
There are two major elements found in nearly all KIMs: a 
cluster of basic residues (Arg or Lys) at the N terminus and 
a hydrophobic motif (A-X-B) near the C terminus [28]. 
The TAB1-KIM peptide does contain one basic residue 
Lys402, however, this residue is disordered in our structure. 
This observation suggests that the CD site for basic resi-
due(s) may contribute little to the p38α-TAB1 interactions. 
On the other hand, the TAB1 peptide forms tight hydropho-
bic interactions through multiple hydrophobic side chains 
with the conserved hydrophobic docking groove of p38α, 
which is composed of helix αD, αE and the reverse turn 
between β7 and β8 in p38α C-lobe (Figures 2A and 3A). 
Previous sequence analysis had suggested that the hydro-
phobic residues Leu407, Leu409 within the predicted 
ΦA-X-ΦB motif and an additional hydrophobic residue 
Pro412 are significant for TAB1 interaction with p38α [27]. 
However, in our complex structure, the p38α docking site 
for the ΦA-X-ΦB motif is bound by the 409LVM411 segment 
of TAB1, inconsistent with previous prediction. Leu409 
nestles into the ΦA binding pocket constituted by the hy-
drophobic side chains of Ile116, Leu122, His126, Val158 
and Cys162, while Met411 makes multiple van der Waals 
contacts with the ΦB site formed by Ala111, Ile116 and 
Glu160 (Figure 3B). In addition to these conventional hy-
drophobic interactions, Pro412 at the ΦB +1 site of 
TAB1-KIM is surrounded by the side chains of Ala111, 
Ile116, Asn115 and Cys119, and Leu407 at the ΦA -2 site 
penetrates into a hydrophobic pocket formed by His126, 
Phe129, Cys162 and Tyr311 (Figure 3C). Furthermore, the 
main chain amide and carbonyl groups of the TAB1 
408SLV410 segment are hydrogen bonded by the side chains 
of His126, Asn120 and the main chain of Glu160 from p38α, 
which further stabilize the interaction between p38α and 
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Figure 2   Structure of the p38α-pepTAB1 complex. A and B, Schematic diagram of the p38α-pepTAB1 structure in two views related by a 90° rotation 
around a vertical axis. The color scheme is p38α (N lobe, pale yellow; C lobe, light orange) and pepTAB1 (cyan). The dotted line in panel A indicates the 
disordered middle portion of p38α activation segment, and that in panel B indicates the distance between the traceable p38α C-terminus and pepTAB1 
N-terminus. C, SA omit map (contoured at 1.5 σ, grey mesh) for the traceable pepTAB1 (residues 406413). 
 
Figure 3  Interaction between p38α and pepTAB1. A, Surface representation of the p38α-pepTAB1 complex. The p38α is colored according to electrostatic 
potential (positive, blue; negative, red), and pepTAB1 is shown in cyan ribbon/sticks. The classical CD and ED sites on p38α for basic residue binding and 
the hydrophobic groove accommodating the ΦA and ΦB side chains of KIMs were indicated. B, Close-up view of the classical hydrophobic binding pockets 
on p38α for pepTAB1 residues Leu409 (ΦA) and Met411 (ΦB). C, Close-up view of two additional hydrophobic binding pockets on p38α for pepTAB1 resi-
dues Leu407 (ΦA-2) and Pro412 (ΦB+1). The hydrogen bonds formed between p38α and pepTAB1 were indicated by blue dashed lines. D, Interactions of 
TAB1 mutants with p38α. The basic and hydrophobic residues on TAB1-KIM peptide were mutated individually, and the p38α interaction of these TAB1 
mutants were examined via size exclusion chromatography.  
TAB1 peptide (Figure 3C). Therefore, the TAB1-KIM pep-
tide binds to the canonical groove of p38α, yet in a similar 
mode from those observed in other p38α-KIM complex 
structures [29,30]. To assess the importance of the observed 
interactions, we carried out site directed mutagenesis anal-
yses on the KIM of TAB1 and examined their effects on the 
p38α-TAB1 interaction by gel filtration. The results corre-
late well with the structure analysis (Figure 3D).  
2.4  Long-range conformational changes of p38α 
To better understand the role of TAB1 peptide binding, we  
compared the p38α-pepTAB1 complex structure with those 
of the inactive unphosphorylated p38α (PDB ID: 1P38) and 
the active dual-phosphorylated p38α (PDB ID: 3PY3) 
[3133]. The binding of TAB1 peptide induces long-range 
conformational changes of p38α (Figure 4). In the reported 
p38α structures, the activation segments between and in-
cluding the important DFG and APE motifs are both 
well-ordered, though adopting distinct conformations (Fig-
ure 4A). However, the middle segment of the activation 
segment (residues 173183) is disordered in our complex 
structure, while the other traceable residues exhibit the same 
conformation as that in the unphosphorylated p38α.  
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Figure 4  TAB1-induced conformational changes of p38α. A, Superposi-
tion of the p38α-pepTAB1 complex (colored as that in Figure 2A) with 
wildtype p38α (PDB ID: 1P38, pale green) and active p38/pTpY (PDB ID: 
3PY3, light pink). B, Close-up view of the salt bridge(s) formed between 
Lys53 and Glu71. The side chains are highlighted as sticks, and the water 
molecule is shown as red dot. C, Close-up view of the ATP binding pocket. 
The ATP molecule is adapted from the structure of p38γ/pTpY (PDB ID: 
1CM8) and shown as black lines.  
One hallmark of protein kinases in their activated state is 
the formation of salt bridge(s) between a Lys on strand β3 
and a Glu from helix αC, where the Lys can interact with 
the α- and β-phosphates of a bound ATP molecule [3436]. 
No salt bridge was observed between the highly conserved 
Lys53 and Glu71 in the unphosphorylated p38α, by contrast, 
a water-mediated hydrogen bond was formed in the du-
al-phosphorylated p38α. Interestingly, a direct salt bridge 
between Lys53 and Glu71 is observed in our p38α-   
pepTAB1 complex structure (Figure 4B). Similar confor-
mational changes occur in complexes between p38α and 
other KIM-peptide, p38α-pepMKK3b (PDB ID: 1LEZ), 
p38α-pepMEF2A (PDB ID: 1LEW) [29].  
Another notable change also occurs at the ATP binding 
pocket, a deep cleft between the N- and C-lobes of p38α 
kinase (Figure 4C). The highly conserved Gly-rich loop lies 
on the top of a bound ATP molecule and plays an important 
role in stabilizing the phosphate groups of ATP [3436]. 
The binding of TAB1 peptide to the inactive p38α induces a 
slightly downward movement of the Gly-rich loop, which 
thus adopts a conformation in between those in the inactive 
and active p38α states. The same is true for the other 
KIM-peptide bound p38 structures [29,35]. The crossover 
linker (107HLMGAD112) connecting the N- and C-lobes of 
p38α constitutes one wall of the ATP-binding pocket, which 
also undergoes conformational change upon TAB1-KIM 
binding. In particular, the side chain of Met109 in the inac-
tive p38α points into the cleft and sterically crash with the 
adenine ring, while Met109 in the fully active p38α, as well 
as in our p38α-pepTAB1 complex, rotates away from the 
active site and occupies a new pocket formed by the β7-β8 
hairpin (Figure 4C). Met109 in the latter cases allows the  
binding of ATP. Thus, the conformational change of the 
crossover connection, particularly that of Met109, may in-
fluence the binding affinity of ATP. Close inspection of the 
peptide bound structures indicate that Met411 (ΦB) and 
Pro412 (ΦB+1) form hydrophobic interactions with the res-
idues within/near the crossover connection, which may af-
fect the orientation of Met109. Therefore, the binding of 
TAB1-KIM peptide induces long-range conformational 
changes of the inactive p38α towards the activated state.  
2.5  The R-spine and C-spine 
To further assess the KIM-induced conformational changes 
of p38α, we then investigated the catalytic spine (C-spine) 
and the regulatory spine (R-spine), two conserved structural 
and functional elements of protein kinases (Figure 5A). The 
integrities of these spines are important for the binding of 
ATP and substrate and thereby imply the active state of 
protein kinases [34]. The C-spine of p38α is composed of 
eight highly conserved hydrophobic residues from both N- 
and C-lobes, consisting of Val38, Ala51, Leu113, Leu156, 
Ala157, Val158, Ile212 and Leu216 (Figure 5B). In partic-
ular, the side chains of Val38, Ala51 from the N-Lobe and 
Ala157 from the C-lobe form a hydrophobic pocket for ac-
commodating the adenine ring of a bound-ATP molecule. 
The p38α-pepTAB1 complex adopts an intermediate con-
formation different from either the inactive or active p38α 
structures. The rest C-spine residues are buried deeply in the 
C-lobe and change little upon KIM peptide binding or 
phosphorylation activation. The R-spine is formed by four 
non-consecutive hydrophobic residues, Leu75 from strand 
β4, Leu86 from the universally conserved helix αC, His148 
on the catalytic loop and Phe169 in the conserved DFG mo-
tif (Figure 5B). Distinct from that in the active p38α struc-
ture, Phe169 in our p38α-TAB1 complex and the inactive 
p38α structure shifts slightly downwards to the C-lobe, 
which only interacts with His148 in the C-lobe, but not 
Leu75 from the N-lobe. In addition, the adjacent Asp168 in 
the DFG motif is inappropriately positioned and thus unable 
to ligate the potential ATP molecule (Figure 5BD). Thus, 
the TAB1-bound p38α does not adopt the fully active con-
formation, which corroborates the slow rate of TAB1-  
induced p38α autophosphorylation.   
In summary, we solved the crystal structure of inactive 
p38α in complex with the KIM peptide derived from TAB1. 
The structure reveals that the TAB1-KIM peptide binds to 
p38α mainly via hydrophobic docking interactions, which 
triggers the inactive p38α to undergo long-range conforma-
tional changes, particularly at the active site, towards the 
active kinase conformation. Notably, the TAB1-KIM bound 
p38α structure yet exhibits significant differences from the 
full active p38α conformation, suggesting that the 
TAB1-KIM peptide alone may be insufficient to trigger the 
full activation of p38α. Nevertheless, we believe that TAB1 
is a reasonable substrate of p38α. In consideration of 
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Figure 5  Comparison of the R-spine and C-spine of p38α-pepTAB1, p38α/WT and p38α/pTpY. The color schemes for the three p38α structures are the 
same as that in Figure 4A, and the helices αC and αF are highlighted as cartoon. A, Residues composing the R-spine and C-spine in the p38α-pepTAB1 
complex are highlighted in green and magenta sticks and surfaces, respectively. B, Close-up view of the R-spine and C-spine in the p38α-pepTAB1 complex. 
C, Close-up view of the R-spine and C-spine in the wildtype p38α structure. D, Close-up view of the R-spine and C-spine in the active p38α/pTpY structure.  
the different roles of TAB1 being a regulator of p38α auto-
phosphorylation and/or a downstream substrate of p38α, we 
aspire to get more information from structural studies of 
p38α in complex with full-length TAB1.  
Crystallographic data were collected at Shanghai Synchrotron Radiation 
Facility beamline 17U. This work was supported in part by National Nat-
ural Science Foundation of China (31130062, 31070643) and Tsinghua 
University (20121080028).  
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